Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 oct. 2019 06h55 HE | Source: Interpace Diagnostics Group, Inc.

Interpace to Present Data at the ATA Annual Meeting

PARSIPPANY, NJ, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Interpace (IDXG) announced today that it will be presenting new data on the performance of its molecular thyroid products at the upcoming 89th...
30 sept. 2019 06h55 HE | Source: Interpace Diagnostics Group, Inc.

Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans

In-Network Access for Thyroid Assays for More than 5 Million Members PARSIPPANY, NJ, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it...
01 mai 2019 06h55 HE | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Publication of Important New Data on Thyroid Test Performance

Data from Registry Study Confirms the Value of ThyGenX® and ThyraMIR® in a Clinical Setting PARSIPPANY, NJ, May 01, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc....
02 avr. 2019 06h55 HE | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica

Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced...
07 nov. 2018 06h55 HE | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing

The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...